Ferry Ossendorp

Affiliated with

Research Area

Biography

Ferry Ossendorp has not added Biography.
If you are Ferry Ossendorp and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2019

Other Publications

Article	Year
Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models. Cells\| PubMed ID: 30959852	2019
Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. The Journal of experimental medicine\| PubMed ID: 9480979	1998
CD4 T cells and their role in antitumor immune responses. The Journal of experimental medicine\| PubMed ID: 10049938	1999
Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. The Journal of experimental medicine\| PubMed ID: 10880536	2000
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28. The Journal of experimental medicine\| PubMed ID: 10952718	2000
Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. The Journal of experimental medicine\| PubMed ID: 11136822	2001
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. The Journal of experimental medicine\| PubMed ID: 11535633	2001
Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. The Journal of cell biology\| PubMed ID: 11581285	2001
Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 11859111	2002
Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12218130	2002
Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cells. Cancer research\| PubMed ID: 12414646	2002
Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunological reviews\| PubMed ID: 12445291	2002
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood\| PubMed ID: 12663445	2003
Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation\| PubMed ID: 14702533	2003
New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides. Nuclear medicine and biology\| PubMed ID: 15246374	2004
Gamma irradiation or CD4+-T-cell depletion causes reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice. Infection and immunity\| PubMed ID: 15845491	2005
Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 15944286	2005
Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16339897	2005
Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo. Molecular immunology\| PubMed ID: 16513171	2006
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nature medicine\| PubMed ID: 16550190	2006
Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16585547	2006
Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo. Immunology\| PubMed ID: 16995881	2006
A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17548593	2007
Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19342659	2009
Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19346487	2009
DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg. European journal of immunology\| PubMed ID: 19544486	2009
Effective CD8(+) T cell priming and tumor protection by enterotoxin B subunit-conjugated peptides targeted to dendritic cells. Vaccine\| PubMed ID: 19576942	2009
Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit beta5t. Chemistry & biology\| PubMed ID: 20797608	2010
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nature immunology\| PubMed ID: 21151101	2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PloS one\| PubMed ID: 21347234	2011
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers. Journal of autoimmunity\| PubMed ID: 21636247	2011
The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21724994	2011
Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo. European journal of immunology\| PubMed ID: 22488363	2012
Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 22649202	2012
Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 22914049	2012
Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles. Cancer immunology, immunotherapy : CII\| PubMed ID: 23613147	2013
Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer. Seminars in immunology\| PubMed ID: 23706598	2013
Controlled local delivery of CTLA-4 blocking antibody induces CD8+ T-cell-dependent tumor eradication and decreases risk of toxic side effects. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23788581	2013
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation. European journal of immunology\| PubMed ID: 23836147	2013
New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 24048903	2013
Local immunomodulation for cancer therapy: Providing treatment where needed. Oncoimmunology\| PubMed ID: 24490127	2013
Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancer. Vaccine\| PubMed ID: 24508038	2014
IgG-mediated anaphylaxis to a synthetic long peptide vaccine containing a B cell epitope can be avoided by slow-release formulation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 24813207	2014
Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V\| PubMed ID: 24820032	2014
Dominant contribution of the proteasome and metalloproteinases to TAP-independent MHC-I peptide repertoire. Molecular immunology\| PubMed ID: 24983205	2014
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 25068703	2014
Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice. PloS one\| PubMed ID: 25137039	2014
FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 25355925	2014
Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen-specific CD8(+) T cell immune re... Biomaterials\| PubMed ID: 25453974	2015
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses. Biomaterials\| PubMed ID: 25465442	2015
Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell death. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 25501579	2015
Two in one: improving synthetic long peptide vaccines by combining antigen and adjuvant in one molecule. Oncoimmunology\| PubMed ID: 25610736	2014
Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 25660830	2015
The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8(+) T cells. Immunity\| PubMed ID: 25979419	2015
Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer. Biomaterials\| PubMed ID: 25993015	2015
Therapeutic cancer vaccines. The Journal of clinical investigation\| PubMed ID: 26214521	2015
The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. eLife\| PubMed ID: 26263500	2015
Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 26546617	2016
TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors. The Journal of clinical investigation\| PubMed ID: 26784543	2016
Vaccines for established cancer: overcoming the challenges posed by immune evasion. Nature reviews. Cancer\| PubMed ID: 26965076	2016
Glycan modification of antigen alters its intracellular routing in dendritic cells, promoting priming of T cells. eLife\| PubMed ID: 26999763	2016
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients. Oncotarget\| PubMed ID: 27564262	2016
The Optimization of Bioorthogonal Epitope Ligation within MHC-I Complexes. ACS chemical biology\| PubMed ID: 27704768	2016
Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds. Nanoscale\| PubMed ID: 27748778	2016
Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination. Molecular pharmaceutics\| PubMed ID: 28088862	2017
C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 28432146	2017
PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy. Oncoimmunology\| PubMed ID: 28507803	2017
CD4 T Cell and NK Cell Interplay Key to Regression of MHC Class I Tumors upon TLR7/8 Agonist Therapy. Cancer immunology research\| PubMed ID: 28637878	2017
PD-L1 immune suppression in cancer: Tumor cells or host cells? Oncoimmunology\| PubMed ID: 28811961	2017
Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8 T Cells. Cancer immunology research\| PubMed ID: 28851692	2017
Linking T cell epitopes to a common linear B cell epitope: A targeting and adjuvant strategy to improve T cell responses. Molecular immunology\| PubMed ID: 29175591	2018
A Restricted Role for FcγR in the Regulation of Adaptive Immunity. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 29523656	2018
Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo. European journal of immunology\| PubMed ID: 29676785	2018
Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified Epitopes. ACS chemical biology\| PubMed ID: 29733186	2018
Formation of Immune Complexes with a Tetanus-Derived B Cell Epitope Boosts Human T Cell Responses to Covalently Linked Peptides in an Ex Vivo Blood Loop System. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 29752315	2018
Approaches to Improve Chemically Defined Synthetic Peptide Vaccines. Frontiers in immunology\| PubMed ID: 29755468	2018
Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 30008371	2018
FcγRI expression on macrophages is required for antibody-mediated tumor protection by cytomegalovirus-based vaccines. Oncotarget\| PubMed ID: 30034625	2018
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model. International journal of cancer\| PubMed ID: 30259976	2019
High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody Therapy. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 30397036	2018
: A workflow for visual and quantitative analysis of flow and mass cytometry data to discover immune signatures and correlations. Computational and structural biotechnology journal\| PubMed ID: 30450167	2018
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy. JCI insight\| PubMed ID: 30518694	2018
Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication. Journal for immunotherapy of cancer\| PubMed ID: 30541631	2018
A Dual-Color Bioluminescence Reporter Mouse for Simultaneous Imaging of T Cell Localization and Function. Frontiers in immunology\| PubMed ID: 30671062	2018
Dual Synthetic Peptide Conjugate Vaccine Simultaneously Triggers TLR2 and NOD2 and Activates Human Dendritic Cells. Bioconjugate chemistry\| PubMed ID: 30865430	2019
Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7. Bioorganic & medicinal chemistry letters\| PubMed ID: 30952595	2019
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors. Journal for immunotherapy of cancer\| PubMed ID: 31412943	2019
Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles. Theranostics\| PubMed ID: 31588231	2019
A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control. Oncoimmunology\| PubMed ID: 31646082	2019
Cationic synthetic long peptides-loaded nanogels: An efficient therapeutic vaccine formulation for induction of T-cell responses. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 31672626	2019